On February 4, Brain&Mind participated in the Elysée Palace to discuss innovation, clinical research and startup financing as part of France2030.
On 4 February, the President of the Republic, Emmanuel Macron, received the leaders of bioclusters as part of the program France2030. This meeting was an opportunity for rich and constructive exchanges to work together as a real “French team” for the development of innovative health products.
Among the topics covered:
This meeting highlights the importance of strengthening France's agility and audacity in the field of health innovation, and of supporting initiatives capable of transforming research and care.
